Pharmacovigilance Tableau Data Analytics Platform: All-in-One Dashboard System for PV Metrics and KPIs

The UBC PV Tableau Data Analytics Platform provides an all-in-one dashboard system for safety Key Performance Indicators (KPIs) analysis and compliance oversight.
Data Liquidity for Clinical Trials: Patient Autonomy and the Rise of AI

UBC and Seqster talked with Chilmark Research about the power of patient-mediated electronic medical record release.
Pharmacovigilance Case Automation Platform: Cost-Efficient Solution to Manage Increased Case Volume

UBC’s PV case automation platform is purpose-built with a focus on customizing our technology for your specific product and program needs.
UBC Perspectives from Asembia’s AXS24 Summit

Patient services are undergoing rapid changes based on regulatory requirements and evolving patient and prescriber expectations.
The Use of AI/ChatGPT in the Preparation of Aggregate Safety Reports & Signal Management Activities

At UBC, we share a vision where AI and safety writing come together to forge a safer path.
Experience the Difference with UBC’s REMS Professionals

At UBC, we are committed to our continued partnership with our customers and to providing exceptional work on behalf of our patients
EDC and PV Safety Database Integration: Practical Application and Implementation

Our PV experts discuss best practices and considerations for implementation involving PV technical, clinical, and operational stakeholders to ensure seamless compatibility.
Enhancing Patient Engagement: Insights from Access USA 2024

Read about three key areas where patient service providers are focusing to better service patients’ needs with advocates and biopharma.
Achieving Global Harmonization: PV & RMP Regulatory Compliance

UBC Pharmacovigilance experts, Helena Pedrosa and Philippe Botteron presented at DIA Europe on how to achieve global harmonization of PV & RMP regulatory compliance.
UBC Participates in Rare Disease Day® at NIH 2024

UBC joined patients, researchers, and industry leaders at this year’s Rare Disease Day at NIH to discuss advancing research, improving diagnostics, and accelerating treatments for those living with rare diseases.